Clover Health (CLOV): Assessing Valuation as 2026 GAAP Profitability Becomes the Next Potential Turning Point [Yahoo! Finance]
Clover Health: Smart Money Should Be Accumulating Ahead Of 2026 GAAP Profits [Seeking Alpha]
Clover Health Investments (NASDAQ:CLOV) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Clover Health Investments (NASDAQ:CLOV) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference